Regents Of The University Of California Natera, Inc. Transaction History

Regents Of The University Of California

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$11.34 - $20.62 $3.72 Million - $6.76 Million	-327,964 Closed	0 $0
Q4 2018 Jan 14, 2019	SELL	$12.32 - $24.38 $1.26 Million - $2.5 Million	-102,370 Reduced 23.79%	327,964 $4.58 Million
Q3 2018 Nov 13, 2018	BUY	$18.82 - $28.96 $8.1 Million - $12.5 Million	430,334 New	430,334 $10.3 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Regents Of The University Of California, based on Form 13F filings with the SEC.

Stay updated on Regents Of The University Of California with notifications on news.